Published online before print January 29, 2004, doi: 10.1161/01.STR.0000117093.59726.F9
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2004;35:660.)
© 2004 American Heart Association, Inc.
Original Contributions |
Association of Infratentorial Brain Arteriovenous Malformations With Hemorrhage at Initial Presentation
From the Stroke Center, Neurological Institute (A.V.K., J.P.M., H.C.S., A.H., H.M., C.S.) and Departments of Interventional Neuroradiology (J.P.-S.) and Medicine (R.R.S.), Columbia University College of Physicians and Surgeons, New York, NY; Department of Neurology, Ernst Moritz Arndt-Universität Greifswald, Germany (A.V.K.); Schlaganfallzentrum Halle, Berufsgenossenschaftliche Kliniken, Bergmannstrost, Halle/Saale, Germany (H.M.); Department of Neurology, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, Berlin, Germany (A.H, C.S.); and Department of Neurology, Hôpital Lariboisière, Paris, France (C.S.).
Correspondence to Alexander V. Khaw, MD, Neurological Institute, Columbia University, Doris & Stanley Tananbaum Stroke Center, NI 6-14, 710 West 168th Street, New York, NY 10032. E-mail akhaw{at}neuro.columbia.edu
 |
Abstract |
|---|
 Top Abstract IntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Background and Purpose— The goal of this study was to analyze the association of hemorrhagic presentation with infratentorial brain arteriovenous malformations (AVMs).
Methods— The 623 consecutive, prospectively enrolled patients from the Columbia AVM Databank were analyzed in a cross-sectional study. Clinical presentation (diagnostic event) was categorized as intracranial hemorrhage or nonhemorrhagic presentation. From brain imaging and cerebral angiography, AVM location was classified as either infratentorial or supratentorial. Univariate and multivariate statistical models were applied to test the effect of age, sex, AVM size and location, venous drainage pattern, and associated (ie, feeding artery or intranidal) arterial aneurysms on the likelihood of hemorrhage at initial AVM presentation.
Results— Of the 623 patients, 72 (12%) had an infratentorial and 551 (88%) had a supratentorial AVM. Intracranial hemorrhage was the presenting symptom in 283 patients (45%), and infratentorial AVM location was significantly more frequent (18%) among patients who bled initially (6%; odds ratio [OR], 3.60; 95% confidence interval [CI], 2.09 to 6.20). This difference remained significant (OR, 1.99; 95% CI, 1.07 to 3.69) in the multivariate logistic regression model controlling for age, sex, AVM size, deep venous drainage, and associated arterial aneurysms. In the same model, the effect of other established determinants for AVM hemorrhage—ie, AVM size (in 1-mm increments; OR, 0.95; 95% CI, 0.94 to 0.96), deep venous drainage (OR, 3.09; 95% CI, 1.87 to 5.12), and associated aneurysms (OR, 2.78; 95% CI, 1.76 to 4.40)—remained significant.
Conclusions— Our findings suggest that infratentorial AVM location is independently associated with hemorrhagic AVM presentation.
Key Words: cerebral arteriovenous malformations • hemorrhage
|
Introduction |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Intracranial hemorrhage is the most feared complication of brain arteriovenous malformations (AVMs). Established morphological risk factors include small AVM nidus size, deep venous drainage, and presence of AVM-related arterial aneurysms.1–7 The impact of AVM location on the risk of rupture, however, remains largely unexplored. We analyzed the effect of infratentorial AVM location on intracranial hemorrhage at initial AVM presentation in a large prospectively enrolled patient sample.
|
Subjects and Methods |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Study Subjects and Data Collection
The Columbia AVM Databank is an ongoing prospective study project collecting demographic, clinical, morphological, and treatment data on consecutive patients with brain AVM admitted to the Columbia-Presbyterian Medical Center since 1989. All AVMs have been diagnosed from brain imaging and cerebral angiography. Other types of intracranial fistulas (such as dural arteriovenous fistulas, vein of Galen malformations) are not included in the data bank. Patients enrolled in the database are drawn from self-referrals and physician referrals from the New York metropolitan area, as well as from distant referral sites. Further details on the Columbia AVM Databank design, variable definitions, and methods have been given in prior publications2,8 and conform to the recently proposed consensus recommendations for AVM research reporting terminology.9 This study includes patients enrolled in the Columbia AVM Databank until October 31, 2002.
The initial AVM presentation (or diagnostic event) was defined as the index clinical event that led to the diagnosis of the AVM. Hemorrhagic presentation was defined as a symptomatic clinical event with signs of fresh intracranial blood on head CT or MRI and/or in the cerebrospinal fluid, leading to the diagnosis of an AVM. Nonhemorrhagic modes of AVM presentation were stratified into seizure, focal neurological deficit, headache, or other/asymptomatic.
Morphological variables tested in the present analysis were anatomic AVM location stratified into supratentorial (any lobar and/or deep cerebral) and infratentorial (brain stem, peduncles, vermis, cerebellar hemisphere, deep cerebellar nuclei, and any combination), AVM size (measured as maximum nidus diameter in millimeters on pretreatment angiography or MR brain imaging), venous drainage pattern (categorized as angiographic drainage into the superficial cortical veins, drainage into the deep venous system, and combined superficial and deep drainage), and presence of associated arterial aneurysms. Arterial aneurysms were defined as saccular dilatations of the lumen 
2 times the width of the arterial vessel that carried the dilatation. A feeding artery was defined as any intracranial vessel that angiographically contributed arterial flow to the malformation. Feeding artery and intranidal aneurysms were considered associated aneurysms with blood flow related to the AVM. The AVM nidus was defined as the vascular mass included in the AVM size measurement. Intranidal aneurysms were coded when visualized early after angiographic injection, eg, before substantial venous filling. Infundibula, arterial ectasias (ie, dilated feeding vessels), and intranidal aneurysmal dilatations seen during the venous angiographic phase only were not coded as arterial aneurysms. Arterial aneurysms located on intracranial arteries not contributing blood flow to the AVM were considered unrelated to the AVM and were not included in the analysis.
Statistical Analysis
Univariate tests (
2 test, t test) and a multivariate logistic regression model including age, sex, AVM location, size, venous drainage pattern, and associated arterial aneurysms were applied to assess the effect of an infratentorial AVM location on hemorrhagic AVM presentation. The attributable risk of infratentorial AVMs for hemorrhagic presentation was determined as described by Fleiss10; the attributable risk (etiologic fraction) measures the relative decrease in the proportion of hemorrhages expected from the elimination of all infratentorial AVMs in the patient sample.
|
Results |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Demographic and morphological baseline characteristics of the total patient sample are given in Table 1. The 72 patients harboring an infratentorial AVM showed the following distribution: 42 affecting the cerebellar hemisphere only; 8 affecting the cerebellar hemisphere and either brain stem, vermis, or peduncle; 6 affecting solely the vermis; 7 in the brain stem only; 7 involving the deep cerebellar nuclei in various combinations; and 1 in the brain stem and peduncles; 1 patient had a large, complex AVM extending from the brain stem through the peduncle and the deep nuclei to the hemispheric surface. From the 623 patients, 283 (45%) were diagnosed because of intracranial hemorrhage. The remaining 340 patients (55%) had a nonhemorrhagic diagnostic event, ie, a seizure (n=182, 29%), headache (n=74, 12%), focal neurological deficit (n=43, 7%), or other clinical events, including incidental AVM diagnoses (n=41, 7%).
|
In the univariate comparison, infratentorial AVM location was significantly more frequent among patients with compared with those without hemorrhagic presentation (Table 1). Furthermore, a significant association with AVM hemorrhage was found for decreasing AVM size, deep venous drainage (either exclusively or combined with superficial venous drainage), and associated arterial aneurysms (Table 1).
In the multivariate model, an independent effect of infratentorial AVM location on presentation with a hemorrhage was found (Table 2). In the same model, AVM size, deep venous drainage, and the presence of AVM-associated arterial aneurysms were significantly associated with hemorrhagic AVM presentation.
|
Compared with supratentorial AVM patients presenting with hemorrhage, infratentorial AVM hemorrhage patients were older and had a higher frequency of feeding artery aneurysms and deep venous drainage component (Table 3).
|
The attributable risk (etiologic fraction) of infratentorial AVMs on presentation with intracranial hemorrhage was 7.7% (95% confidence interval [CI], 4.3 to 11.0).
|
Discussion |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
Prior studies already found higher frequencies of AVM rupture in patients with malformations in the brain stem or cerebellum.1,4,11,12 However, results on statistically independent associations of infratentorial AVM location and hemorrhagic presentation were inconsistent, probably because of methodological limitations. Particularly, studies derived from patient samples before the era of noninvasive brain imaging11 may overestimate the frequency of intracranial hemorrhage when diagnosed solely on the basis of clinical criteria. Although nonuniform results among smaller series on the association of AVM location and presentation with hemorrhage are readily explained by subgroup sizes that are insufficient for computing multivariate models,4,12 even larger-scale registries show contradictory findings from multivariate analyses despite the repeatedly significant association of infratentorial location for hemorrhagic presentation in univariate tests. In a recent study by the Toronto Study Group,13 the rate of hemorrhage among patients with infratentorial AVM (60%) was similar to our findings and roughly twice as high as in supratentorial AVM cases (35%). The positive association of deep location with hemorrhagic presentation in multivariate analysis, however, may not be directly comparable to our results because most of the patients in this subgroup had supratentorial deep AVMs (callosal and thalamic). Finally, in a cross-sectional study of 662 consecutive patients from 3 centers, Mansmann et al14 also found a higher frequency of posterior fossa AVMs among patients with initial hemorrhage. Their finding, however, did not sustain significance in multivariate models. Therefore, this study is the first to elicit a statistically independent association of infratentorial AVM location with hemorrhage at initial presentation in a large, prospective data set.
Most other studies reported rates of infratentorial AVM location comparable to our sample.13–16 Possible limitations of our findings arising from tertiary referral center bias17 are therefore less likely but need to be elucidated in population-based datasets. Furthermore, by corroborating the effects of other determinants for hemorrhagic AVM presentation such as small AVM size, deep venous drainage pattern, and associated arterial aneurysms, the findings from our study sample lend support to prior work from other investigators.1,4,12,14 However, population-based fatality rates after AVM hemorrhage are as yet unknown, and referral center patient cohorts may generally underestimate the overall frequency of AVM hemorrhage.18 The possibility of a systematic error in the analyses can therefore not be excluded entirely. Also, our study was performed on the basis of data referring to initial AVM presentation and does not allow direct linear extensions to the risk of future hemorrhage. Some currently available data on the effect of morphological characteristics on recurrent AVM hemorrhage were unable to confirm the risk models for initial hemorrhage.2,19
Infratentorial AVMs are conceivably less likely to induce seizures. Thus, a relative increase in hemorrhagic presentation compared with supratentorial AVMs may be expected. In an exploratory model eliminating all patients presenting with seizure, the proportion of hemorrhagic presentation among patients with infratentorial AVMs (72%) still exceeded the frequency among those with supratentorial AVMs (231 of 369 patients, 63%), but the difference did not reach statistical significance (2; P=0.12). The actual effect size of infratentorial location for the risk of hemorrhagic AVM presentation may therefore be low. This is reflected in the small etiologic fraction of 
8%, ie, only 1 of 13 initial AVM hemorrhages would have been avoided if all infratentorial AVMs had been eliminated. The etiologic fraction (attributable risk) and the modest odds ratio (OR) and its lower CI value close to unity suggest a significant but small effect size on hemorrhagic AVM presentation.
In conclusion, our data suggest that infratentorial AVM location is independently associated with hemorrhagic AVM presentation. The significant age difference between the supratentorial and infratentorial hemorrhage groups as seen in the univariate model did not sustain multivariate analysis, suggesting that age at presentation may interact with infratentorial AVM diagnosis but not with hemorrhagic presentation.20 Because our cross-sectional study did not analyze the effect of infratentorial AVM location on the risk of future hemorrhage, no immediate treatment recommendations can be derived from our data. The results, however, emphasize the need for prospective data on natural history and risk predictors from population-based studies.21,22 Definite treatment recommendations may be drawn only from a clinical trial testing the long-term benefit of "invasive" treatment compared with best medical therapy in a cohort that also includes infratentorial AVMs. Our findings may provide additional information for prespecified subgroup analyses in the planning of future prospective AVM studies.
|
Acknowledgments |
|---|
This study is supported in part by NIH grant RO1 40792-01 (principal investigator, Dr Mohr). Dr Khaw is supported by a research grant from the Alfried Krupp von Bohlen und Halbach-Stiftung, Essen, Germany; Drs Khaw and Schumacher are supported by the Horace W. Goldsmith Foundation, New York.
Received September 3, 2003; revision received October 29, 2003; accepted November 19, 2003.
|
References |
|---|
|
TopAbstractIntroductionSubjects and MethodsResultsDiscussionReferences |
|---|
1. Marks MP, Lane B, Steinberg GK, Chang PJ. Hemorrhage in intracerebral arteriovenous malformations: angiographic determinants. Radiology. 1990; 176: 807–813.
2. Mast H, Young WL, Koennecke HC, Sciacca RR, Osipov A, Pile-Spellman J, Hacein-Bey L, Duong HD, Stein BM, Mohr JP. Risk of spontaneous hemorrhage after diagnosis of cerebral arteriovenous malformations. Lancet. 1997; 350: 1065–1068.[CrossRef][Medline] [Order article via Infotrieve]
3. Duong HD, Young WL, Vang MC, Sciacca RR, Mast H, Koennecke HC, Hartmann A, Joshi S, Mohr JP, Pile-Spellman J. Feeding artery pressure and venous drainage pattern are primary determinants of hemorrhage from cerebral arteriovenous malformations. Stroke. 1998; 29: 1167–1176.
4. Langer DJ, Lasner TM, Hurst RW, Flamm ES, Zager EL, King JT. Hypertension, small size, and deep venous drainage are associated with risk of hemorrhagic presentation of cerebral arteriovenous malformations. Neurosurgery. 1998; 42: 481–489.[Medline] [Order article via Infotrieve]
5. Thompson RC, Steinberg GK, Levy RP, Marks MP. The management of patients with arteriovenous malformations and associated intracranial aneurysms. Neurosurgery. 1998; 43: 202–212.[CrossRef][Medline] [Order article via Infotrieve]
6. Redekop G, terBrugge K, Montanera W, Willinsky R. Arterial aneurysms associated with cerebral arteriovenous malformation: classification, incidence, and risk of hemorrhage. J Neurosurg. 1998; 89: 539–546.[Medline] [Order article via Infotrieve]
7. Stapf C, Mohr JP, Pile-Spellman J, Sciacca RR, Hartmann A, Schumacher HC, Mast H. Concurrent arterial aneurysms in brain arteriovenous malformations with haemorrhagic presentation. J Neurol Neurosurg Psychiatry. 2002; 73: 294–298.
8. Hartmann A, Mast H, Mohr JP, Koennecke HC, Osipov A, Pile-Spellman J, Duong HD, Young WL. Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation. Stroke. 1998; 29: 931–934.
9. Joint Writing Group of the Technology Assessment Committee, American Society of Interventional and Therapeutic Neuroradiology; Joint Section on Cerebrovascular Neurosurgery, a Section of the American Association of Neurological Surgeons and Congress of Neurological Surgeons; and Section of Stroke and the Section of Interventional Neurology of the American Academy of Neurology. Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke. 2001; 32: 1430–1442.
10. Fleiss JL. Inference about population attributable risk from cross-sectional studies. Am J Epidemiol. 1979; 110: 103–104.
11. Perret G, Nishioka H. Report on the Cooperative Study of Intracranial Aneurysms and Subarachnoid Hemorrhage, Section VI, Arteriovenous Malformations: an analysis of 545 cases of cranio-cerebral arteriovenous malformations and fistulae reported to the cooperative study. J Neurosurg. 1966; 25: 467–490.[Medline] [Order article via Infotrieve]
12. Turjman F, Massoud TF, Vinuela F, Sayre JW, Guglielmi G, Duckwiler G. Correlation of the angioarchitectural features of cerebral arteriovenous malformations with clinical presentation of hemorrhage. Neurosurgery. 1995; 37: 856–860.[Medline] [Order article via Infotrieve]
13. Stefani MA, Porter PJ, terBrugge KG, Montanera W, Willinsky RA, Wallace C. Angioarchitectural factors present on brain arteriovenous malformations associated with hemorrhagic presentation. Stroke. 2002; 33: 920–924.
14. Mansmann U, Meisel J, Brock M, Rodesch G, Hortenzia A, Lasjaunias P. Factors associated with intracranial hemorrhage in cases of cerebral arteriovenous malformation. Neurosurgery. 2000; 46: 272–281.[CrossRef][Medline] [Order article via Infotrieve]
15. Crawford PM, West CR, Chadwick DW, Shaw MDM. Arteriovenous malformations of the brain: natural history in unoperated patients. J Neurol Neurosurg Psychiatry. 1986; 49: 1–10.
16. Al-Shahi R, Fang JSY, Lewis SC, Warlow CP. Prevalence of adults with brain arteriovenous malformations: a community based study in Scotland using capture-recapture analysis. J Neurol Neurosurg Psychiatry. 2002; 73: 547–551.
17. Hofmeister C, Stapf C, Hartmann A, Sciacca RR, Mansmann U, terBrugge K, Lasjaunias P, Mohr JP, Mast H, Meisel J. Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformations. Stroke. 2000; 31: 1307–1310.
18. Brown RD Jr, Wiebers DO, Torner JC, O’Fallon WM. Incidence and prevalence of intracranial vascular malformations in Olmsted County, Minnesota, 1965 to 1992. Neurology. 1996; 46: 949–952.
19. Stefani MA, Porter PJ, terBrugge KG, Montanera W, Willinsky RA, Wallace C. Large and deep brain arteriovenous malformations are associated with risk of future hemorrhage. Stroke. 2002; 33: 1220–1224.
20. Stapf C, Khaw AV, Sciacca RR, Hofmeister C, Schumacher HC, Pile-Spellman J, Mast H, Mohr JP, Hartmann A. Effect of age on clinical and morphological characteristics in patients with brain arteriovenous malformation. Stroke. 2003; 34: 2664–2669.
21. Al-Shahi R, Bhattacharya JJ, Currie DG, Papanastassiou V, Ritchie V, Roberts RC, Sellar RJ, Warlow C. Prospective, population-based detection of intracranial vascular malformations in adults. Stroke. 2003; 34: 1163–1169.
22. Stapf C, Mast H, Sciacca RR, Berenstein A, Nelson PK, Gobin YP, Pile-Spellman J, Mohr JP. The New York Islands AVM Study: design, study progress, and initial results. Stroke. 2003; 34: e29–e33.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  L da Costa, L Thines, A R Dehdashti, M C Wallace, R A Willinsky, M Tymianski, M L Schwartz, and K G t. Brugge Management and clinical outcome of posterior fossa arteriovenous malformations: report on a single-centre 15-year experience J. Neurol. Neurosurg. Psychiatry, April 1, 2009; 80(4): 376 - 379. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. da Costa, M. C. Wallace, K. G. ter Brugge, C. O'Kelly, R. A. Willinsky, and M. Tymianski The Natural History and Predictive Features of Hemorrhage From Brain Arteriovenous Malformations Stroke, January 1, 2009; 40(1): 100 - 105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Dashe, C. Stapf, and J .P. Mohr Predictors of hemorrhage in patients with untreated brain arteriovenous malformation Neurology, February 13, 2007; 68(7): 535 - 535. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||